Drug Trial Radar · NCT00049829
HORIZON-PFT: Pivotal Fracture Trial
Last checked: Nov 19, 2026Latest source record: Nov 2, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7,700
Actual
Start
Jan 2002
Primary completion
Jun 2006
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Nov 15, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- Female only, from 65 years, up to 89 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
HORIZON-PFT (Pivotal Fracture Trial) will study the effect of zoledronic acid, given once per year, on the treatment of osteoporosis in women past menopause. Hip and vertebral fractures are the most devastating consequences of osteoporosis. HORIZON-PFT is designed to determine the benefits of zoledronic acid in fracture reduction at both the hip and spine.
Conditions
- Osteoporosis
Interventions
Zoledronic AcidDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of hip fxs
- Incidence of new vertebral fxs
Locations
60 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Arizona Arthritis Research
Paradise Valley, Arizona
Southern Arizona VA
Tucson, Arizona
University of Arkansas for Medical Science
Little Rock, Arkansas
Osteoporosis Medical Center
Beverly Hills, California
Orthopaedic Hospital
Los Angeles, California
The Foundation for Osteoporosis Research and Education
Oakland, California
University of California Davis- Gen Med Research
Sacramento, California
Osteoporosis Prevention Center
San Diego, California
Radiant Research- San Diego
San Diego, California
Diablo Clinical Research, Inc
Walnut Creek, California
Colorado Center for Bone Research
Lakewood, Colorado
Longmont Medical Research Network
Longmont, Colorado
Northeast Clinical Research
Hamden, Connecticut
Health Core
Newark, Delaware
CRA Research
Fort Lauderdale, Florida
Anchor Research Center
Naples, Florida
Sarasota Arthritis Center
Sarasota, Florida
Radiant
Stuart, Florida
Comprehensive Clinical Trials, LLC
West Palm Beach, Florida
Palm Beach Research Center
West Palm Beach, Florida
United Osteoporosis Centers (UOC)
Gainesville, Georgia
Northwestern University Center for Clinical Research
Chicago, Illinois
School of Medicine
Indianapolis, Indiana
Medical Specialists
Munster, Indiana
Heartland Research Associates, LLC
Wichita, Kansas
Center for Arthritis and Osteoporosis
Elizabethtown, Kentucky
Maine Center for Osteoporosis Research and Education
Bangor, Maine
Osteoporosis Clinical Trial Center
Hagerstown, Maryland
Brigham and Women's Hospital
Boston, Massachusetts
Clinical Pharmacology Study Groups
Worcester, Massachusetts
Washington University School of Medicine
St Louis, Missouri
Arthritis Regional Research Center
Mercerville, New Jersey
Phoenix OB-GYN Associates, LLC
Moorestown, New Jersey
New Mexico Clinical Research and Osteoporosis Center, Inc
Albuquerque, New Mexico
Endwell Family Physicians
Endwell, New York
Winthrop U Hospital
Mineola, New York
Internal Medicine Associates
Fargo, North Dakota
University of Cincinnati Bone Health and Osteoporosis Center
Cincinnati, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.